Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SOLESENCE, INC.SLSN · Entity 7041 | 10% owner | May 29, 2025 | June 02, 2025 |
| ULTRALIFE CORPULBI · Entity 6735 | Director · 10% owner | May 21, 2026 | May 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SOLESENCE, INC.
Report date May 29, 2025 · Filed June 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Strandler, LLC | 30,373,270 |
Last balance in matching sequence
After 2025-05-29 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2025-05-29 · Purchase · Acquired 2,500,000 · Balance 26,184,270 F1: As manager of Strandler, LLC, Bradford T. Whitmore is the indirect beneficial owner of these shares. Row 2 · 2025-05-29 · Purchase · Acquired 4,189,000 · Balance 30,373,270 F1: As manager of Strandler, LLC, Bradford T. Whitmore is the indirect beneficial owner of these shares. |
| Common StockSEC Table I · non-derivative | IndirectBy Whitmore Holdings, LLC | 18,669,879 |
Last balance in matching sequence
After 2025-05-29 transaction · row 4
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 3 · 2025-05-29 · Sale · Disposed 2,500,000 · Balance 22,858,879 F2: As manager of Whitmore Holdings, LLC (and trustee of Bradford Whitmore Trust, the sole member of Whitmore Holdings, LLC), Bradford T. Whitmore is the indirect beneficial owner of these shares. Row 4 · 2025-05-29 · Sale · Disposed 4,189,000 · Balance 18,669,879 F2: As manager of Whitmore Holdings, LLC (and trustee of Bradford Whitmore Trust, the sole member of Whitmore Holdings, LLC), Bradford T. Whitmore is the indirect beneficial owner of these shares. |
| Common StockSEC Table I · non-derivative | Direct | 108,141 |
Reported balance
Holding disclosure · report date 2025-05-29 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 108,141 |
| Common StockSEC Table I · non-derivative | IndirectBy Grace Investments, LP | 675,515 |
Reported balance
Holding disclosure · report date 2025-05-29 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 675,515 F3: As manager of INV-GP, LLC, which is the General Partner of Grace Investments, LP, Bradford T. Whitmore is the indirect beneficial owner of these shares. |
Filing footnotes · ownership attribution and instrument terms
F1: As manager of Strandler, LLC, Bradford T. Whitmore is the indirect beneficial owner of these shares.
F2: As manager of Whitmore Holdings, LLC (and trustee of Bradford Whitmore Trust, the sole member of Whitmore Holdings, LLC), Bradford T. Whitmore is the indirect beneficial owner of these shares.
F3: As manager of INV-GP, LLC, which is the General Partner of Grace Investments, LP, Bradford T. Whitmore is the indirect beneficial owner of these shares.
ULTRALIFE CORP
Report date May 21, 2026 · Filed May 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Whitmore Holdings, LLC | 2,050,637 |
Last balance in matching sequence
After 2026-05-26 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2026-05-21 · Purchase · Acquired 32,876 · Balance 1,974,635 F1: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.97 to $6.359. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. F2: As manager of Whitmore Holdings, LLC (and trustee of Bradford Whitmore Trust, the sole member of Whitmore Holdings, LLC), Bradford T. Whitmore is the indirect beneficial owner of these shares. Row 2 · 2026-05-22 · Purchase · Acquired 8,700 · Balance 1,983,335 F3: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.2953 to $6.3995. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. F2: As manager of Whitmore Holdings, LLC (and trustee of Bradford Whitmore Trust, the sole member of Whitmore Holdings, LLC), Bradford T. Whitmore is the indirect beneficial owner of these shares. Row 3 · 2026-05-26 · Purchase · Acquired 67,302 · Balance 2,050,637 F4: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.6399 to $6.9499. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. F2: As manager of Whitmore Holdings, LLC (and trustee of Bradford Whitmore Trust, the sole member of Whitmore Holdings, LLC), Bradford T. Whitmore is the indirect beneficial owner of these shares. |
| Common StockSEC Table I · non-derivative | Direct | 205,915 |
Reported balance
Holding disclosure · report date 2026-05-21 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 205,915 |
| Common StockSEC Table I · non-derivative | IndirectBy SUNRAY I, LLC | 4,452,283 |
Reported balance
Holding disclosure · report date 2026-05-21 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 4,452,283 F5: As manager of Sunray I, LLC, Bradford T. Whitmore is an indirect beneficial owner of 4,452,283 shares of Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.97 to $6.359. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.
F2: As manager of Whitmore Holdings, LLC (and trustee of Bradford Whitmore Trust, the sole member of Whitmore Holdings, LLC), Bradford T. Whitmore is the indirect beneficial owner of these shares.
F3: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.2953 to $6.3995. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.
F4: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.6399 to $6.9499. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.
F5: As manager of Sunray I, LLC, Bradford T. Whitmore is an indirect beneficial owner of 4,452,283 shares of Common Stock.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Clearside Biomedical, Inc.
Report date February 07, 2024 · Filed February 09, 2024
Section 16 reporting ended · disclosed 2024-02-09. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,495,034 |
Reported balance
After 2024-02-07 transaction · row 1
1 source rowRow 1 · 2024-02-07 · Purchase · Acquired 444,444 · Balance 4,495,034 |
| WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $1.62 · Expires 2029-08-09 | Direct | 444,444 |
Reported balance
After 2024-02-07 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-02-07 · Purchase · Acquired 444,444 · Balance 444,444 |
| Common StockSEC Table I · non-derivative | Indirectby Grace Brothers, LP | 2,350,152 |
Reported balance
Holding disclosure · report date 2024-02-07 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,350,152 F1: As General Partner of Grace Brothers, LP, Bradford T. Whitmore is an indirect beneficial owner of 2,350,152 shares of Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: As General Partner of Grace Brothers, LP, Bradford T. Whitmore is an indirect beneficial owner of 2,350,152 shares of Common Stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 02, 2023 Filed Jun 5, 2023 19:22 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock | 5,964 | $4.40 | $26,242.20 |
DisclosureSEC source: 0000933430-23-000007 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,080,396 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.3832 to $4.5. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| June 01, 2023 Filed Jun 1, 2023 20:55 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock | 20,247 | $4.33 | $87,606.74 |
DisclosureSEC source: 0000933430-23-000006 · primary_doc.xml · nonDerivative · entry 3 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,074,432 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.2562 to $4.35. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions on this Form 4. Read SEC document |
| June 01, 2023 Filed Jun 1, 2023 20:34 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 500 | $1.21 | $602.50 |
DisclosureSEC source: 0000933430-23-000005 · primary_doc.xml · nonDerivative · entry 3 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,321,021 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.1739 to $1.2226. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on the Form 4. Read SEC document |
| May 31, 2023 Filed Jun 1, 2023 20:55 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock | 7,216 | $4.28 | $30,883.76 |
DisclosureSEC source: 0000933430-23-000006 · primary_doc.xml · nonDerivative · entry 2 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,054,185 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.23 to $4.29. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| May 31, 2023 Filed Jun 1, 2023 20:34 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 7,700 | $1.18 | $9,079.07 |
DisclosureSEC source: 0000933430-23-000005 · primary_doc.xml · nonDerivative · entry 2 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,320,521 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.15 to $1.20. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on the Form 4. Read SEC document |
| May 30, 2023 Filed Jun 1, 2023 20:55 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock | 6,500 | $4.29 | $27,901.25 |
DisclosureSEC source: 0000933430-23-000006 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,046,969 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.2598 to $4.3184. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| May 30, 2023 Filed Jun 1, 2023 20:34 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 8,200 | $1.18 | $9,646.48 |
DisclosureSEC source: 0000933430-23-000005 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,312,821 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.1125 to $1.20. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on the Form 4. Read SEC document |
| May 19, 2023 Filed May 19, 2023 20:16 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 5,650 | $1.19 | $6,737.06 |
DisclosureSEC source: 0000933430-23-000004 · primary_doc.xml · nonDerivative · entry 3 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,304,621 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.1532 to $1.2027. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on the Form 4. Read SEC document |
| May 18, 2023 Filed May 19, 2023 20:16 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 8,200 | $1.04 | $8,541.12 |
DisclosureSEC source: 0000933430-23-000004 · primary_doc.xml · nonDerivative · entry 2 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,298,971 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.0 to $1.05. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on the Form 4. Read SEC document |
| May 17, 2023 Filed May 19, 2023 20:16 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 53,040 | $0.77 | $40,920.36 |
DisclosureSEC source: 0000933430-23-000004 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,290,771 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.5798 to $1.0279. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on the Form 4. Read SEC document |
| May 11, 2023 Filed May 11, 2023 20:51 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock | 20,256 | $4.08 | $82,652.58 |
DisclosureSEC source: 0000933430-23-000003 · primary_doc.xml · nonDerivative · entry 3 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,040,469 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.044 to $4.11. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| May 10, 2023 Filed May 11, 2023 20:51 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock | 3,979 | $4.03 | $16,045.72 |
DisclosureSEC source: 0000933430-23-000003 · primary_doc.xml · nonDerivative · entry 2 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,020,213 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.0 to $4.05. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| May 09, 2023 Filed May 11, 2023 20:51 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock | 4,553 | $3.97 | $18,084.52 |
DisclosureSEC source: 0000933430-23-000003 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,016,234 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.9398 to $4.0199. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| March 13, 2023 Filed Mar 13, 2023 20:37 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock | 14,338 | $4.07 | $58,355.66 |
DisclosureSEC source: 0000933430-23-000002 · primary_doc.xml · nonDerivative · entry 3 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,011,681 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.9597 to $4.1137. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| March 10, 2023 Filed Mar 13, 2023 20:37 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock | 10,100 | $4.05 | $40,894.90 |
DisclosureSEC source: 0000933430-23-000002 · primary_doc.xml · nonDerivative · entry 2 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 997,343 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.025 to $4.0599. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 20:37 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock | 5,562 | $4.07 | $22,642.35 |
DisclosureSEC source: 0000933430-23-000002 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 987,243 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.035 to $4.08. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| December 16, 2022 Filed Dec 16, 2022 18:29 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock | 7,200 | $3.98 | $28,682.64 |
DisclosureSEC source: 0000933430-22-000012 · primary_doc.xml · nonDerivative · entry 3 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 981,681 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.94 to $4.00. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| December 15, 2022 Filed Dec 15, 2022 21:22 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 300,488 | $1.10 | $330,596.90 |
DisclosureSEC source: 0000933430-22-000010 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,237,731 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.10 to $1.195. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on the Form 4. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 18:29 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock | 5,138 | $3.94 | $20,248.86 |
DisclosureSEC source: 0000933430-22-000012 · primary_doc.xml · nonDerivative · entry 2 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 974,481 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.91 to $3.95. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 15:17 UTC Amendment | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 300,488 | $1.10 | $330,596.90 |
DisclosureSEC source: 0000933430-22-000011 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,237,731 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.10 to $1.195. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on the Form 4. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 18:29 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock | 25,694 | $4.01 | $103,030.37 |
DisclosureSEC source: 0000933430-22-000012 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 969,343 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.925 to $4.05. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| December 08, 2022 Filed Dec 8, 2022 22:09 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock | 28,600 | $4.12 | $117,820.56 |
DisclosureSEC source: 0000933430-22-000009 · primary_doc.xml · nonDerivative · entry 3 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 943,649 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.95 to $4.2399. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| December 08, 2022 Filed Dec 8, 2022 21:46 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 92,000 | $1.16 | $107,032.80 |
DisclosureSEC source: 0000933430-22-000008 · primary_doc.xml · nonDerivative · entry 3 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,937,243 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.1503 to $1.2069. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on the Form 4. Read SEC document |
| December 07, 2022 Filed Dec 8, 2022 22:09 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock | 19,600 | $3.97 | $77,774.76 |
DisclosureSEC source: 0000933430-22-000009 · primary_doc.xml · nonDerivative · entry 2 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 915,049 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.90 to $3.9999. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| December 07, 2022 Filed Dec 8, 2022 21:46 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 450 | $1.17 | $526.50 |
DisclosureSEC source: 0000933430-22-000008 · primary_doc.xml · nonDerivative · entry 2 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,845,243 Read SEC document |
| December 06, 2022 Filed Dec 8, 2022 22:09 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock | 20,996 | $3.96 | $83,133.66 |
DisclosureSEC source: 0000933430-22-000009 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 895,449 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.84 to $4.00. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| December 06, 2022 Filed Dec 8, 2022 21:46 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 86,318 | $1.22 | $105,307.96 |
DisclosureSEC source: 0000933430-22-000008 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,844,793 Read SEC document |
| November 18, 2022 Filed Nov 18, 2022 21:28 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 73,400 | $1.40 | $102,760.00 |
DisclosureSEC source: 0000933430-22-000007 · primary_doc.xml · nonDerivative · entry 3 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,758,475 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.395 to $1.40. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| November 17, 2022 Filed Nov 18, 2022 21:28 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 47,160 | $1.38 | $65,076.08 |
DisclosureSEC source: 0000933430-22-000007 · primary_doc.xml · nonDerivative · entry 2 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,685,075 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.30 to $1.40. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on the Form 4. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 21:28 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 12,625 | $1.40 | $17,662.38 |
DisclosureSEC source: 0000933430-22-000007 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,637,915 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.38 to $1.40. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on the Form 4. Read SEC document |
| August 18, 2022 Filed Aug 19, 2022 20:03 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock | 17,700 | $4.64 | $82,211.19 |
DisclosureSEC source: 0000933430-22-000006 · primary_doc.xml · nonDerivative · entry 2 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 874,453 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.61 to $4.66. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 20:03 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock | 16,400 | $4.60 | $75,417.04 |
DisclosureSEC source: 0000933430-22-000006 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 856,753 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.55 to $4.6449. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| August 04, 2022 Filed Aug 4, 2022 20:54 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock | 40,052 | $4.73 | $189,257.72 |
DisclosureSEC source: 0000933430-22-000005 · primary_doc.xml · nonDerivative · entry 3 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 840,353 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.71 to $4.75. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| August 03, 2022 Filed Aug 4, 2022 20:54 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock | 29,100 | $4.68 | $136,330.59 |
DisclosureSEC source: 0000933430-22-000005 · primary_doc.xml · nonDerivative · entry 2 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800,301 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.60 to $4.79. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a securtiy holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| August 02, 2022 Filed Aug 4, 2022 20:54 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock | 30,848 | $4.60 | $141,897.72 |
DisclosureSEC source: 0000933430-22-000005 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 771,201 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.5922 to $4.61. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| June 08, 2022 Filed Jun 8, 2022 20:06 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock | 30,690 | $5.20 | $159,554.24 |
DisclosureSEC source: 0000933430-22-000003 · primary_doc.xml · nonDerivative · entry 2 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 740,353 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.15 to $5.25. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 20:06 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock | 12,280 | $4.86 | $59,697.99 |
DisclosureSEC source: 0000933430-22-000003 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 709,663 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.835 to $4.9099. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| February 28, 2022 Filed Feb 28, 2022 21:43 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock | 30 | $5.22 | $156.60 |
DisclosureSEC source: 0000933430-22-000002 · primary_doc.xml · nonDerivative · entry 3 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 697,383 Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 21:43 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock | 100 | $5.14 | $514.00 |
DisclosureSEC source: 0000933430-22-000002 · primary_doc.xml · nonDerivative · entry 2 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 697,353 Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 21:43 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock | 54,900 | $4.44 | $244,019.52 |
DisclosureSEC source: 0000933430-22-000002 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 697,253 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.43 to $4.45. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| December 21, 2021 Filed Dec 23, 2021 21:28 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 7,731,573 | $4.19 | $32,361,271.95 |
DisclosureSEC source: 0000933430-21-000008 · primary_doc.xml · nonDerivative · entry 2 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Strandler, LLC Disclosed balance after: 7,731,573 F1 · ownership.direct: As sole manager and sole voting member of Strandler, LLC, Bradford T. Whitmore is an indirect beneficial owner of 7,731,573 shares of Common Stock. Read SEC document |
| December 21, 2021 Filed Dec 23, 2021 21:28 UTC | SOLESENCE, INC. NANX · Entity 7041 | SaleCommon Stock | 7,731,573 | $4.19 | $32,361,271.95 |
DisclosureSEC source: 0000933430-21-000008 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,893,717 Read SEC document |
| December 17, 2021 Filed Dec 20, 2021 21:11 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock | 53,251 | $5.57 | $296,624.05 |
DisclosureSEC source: 0000933430-21-000006 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 642,353 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.445 to $5.88. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| September 01, 2021 Filed Sep 1, 2021 20:46 UTC | Clearside Biomedical, Inc. CLSD · Entity 82875 | SaleCommon Stock | 213,203 | $6.89 | $1,469,245.83 |
DisclosureSEC source: 0000933430-21-000005 · primary_doc.xml · nonDerivative · entry 3 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Grace Brothers, LP Disclosed balance after: 2,415,056 F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.66 to $7.09. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. F2 · ownership.direct: As General Partner of Grace Brothers, LP, Bradford T. Whitmore is an indirect beneficial owner of 2,415,056 shares of Common Stock. Read SEC document |
| August 31, 2021 Filed Sep 1, 2021 20:46 UTC | Clearside Biomedical, Inc. CLSD · Entity 82875 | SaleCommon Stock | 107,682 | $6.96 | $749,079.06 |
DisclosureSEC source: 0000933430-21-000005 · primary_doc.xml · nonDerivative · entry 2 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Grace Brothers, LP Disclosed balance after: 2,628,259 F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.8499 to $7.21. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. F2 · ownership.direct: As General Partner of Grace Brothers, LP, Bradford T. Whitmore is an indirect beneficial owner of 2,415,056 shares of Common Stock. Read SEC document |
| August 30, 2021 Filed Sep 1, 2021 20:46 UTC | Clearside Biomedical, Inc. CLSD · Entity 82875 | SaleCommon Stock | 99,400 | $7.06 | $702,101.96 |
DisclosureSEC source: 0000933430-21-000005 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Grace Brothers, LP Disclosed balance after: 2,735,941 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.97 to $7.42. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. F2 · ownership.direct: As General Partner of Grace Brothers, LP, Bradford T. Whitmore is an indirect beneficial owner of 2,415,056 shares of Common Stock. Read SEC document |
| August 04, 2021 Filed Aug 4, 2021 19:55 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 7,687 | $7.97 | $61,258.47 |
DisclosureSEC source: 0000933430-21-000004 · primary_doc.xml · nonDerivative · entry 3 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 589,102 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.94 to $8.0099. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 19:55 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 12,400 | $7.85 | $97,359.84 |
DisclosureSEC source: 0000933430-21-000004 · primary_doc.xml · nonDerivative · entry 2 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 581,415 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.755 to $8.0099. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 19:55 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 5,113 | $7.95 | $40,652.95 |
DisclosureSEC source: 0000933430-21-000004 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 569,015 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.92 to $8.00. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| May 07, 2021 Filed May 11, 2021 20:37 UTC | SOLESENCE, INC. NANX · Entity 7041 | Conversion2% Second Secured Convertible Note · Derivative | 2,019,111 | $0.20 Strike: $0.20 | $403,822.20 |
DisclosureSEC source: 0000933430-21-000003 · primary_doc.xml · derivative · entry 4 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,095,555 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The principal and outstanding accrued and unpaid interest on the Convertible Note converted at a price of $.20 per share. F1 · kind: Pursuant to the terms of the 2% Second Secured Convertible Note (the "Convertible Note"), the reporting person acquired: (i) 10,000,000 shares of Common Stock upon conversion of $2,000,000 in principal amount of the Convertible Note; and (ii) 95,555 shares of Common Stock upon the conversion of $19,111.11 of outstanding accrued and unpaid interest on the Convertible Note through May 7, 2021, the conversion exercise date. F2 · price: The principal and outstanding accrued and unpaid interest on the Convertible Note converted at a price of $.20 per share. F4 · derivative.exercise_date: Pursuant to the terms of the Convertible Note, conversion may be undertaken prior to the Convertible Note's maturity date. The reporting person elected to exercise his conversion right in full on May 7, 2021. F5 · derivative.expiration_date: The Convertible Note had a maturity date of May 15, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.